I think ANO , AD8 and EVS could the near term contributors to...

  1. 2,806 Posts.
    lightbulb Created with Sketch. 428
    I think ANO , AD8 and EVS could the near term contributors to total returns in the weeks ahead, AD8 due to 4C release soon which could be a catalyst and EVS could move higher once whoever is selling has finished his/her selling.


    Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7
    0   OPPORTUNITY STOCKS Date stock mentioned in Its Over thread Open price on date stock mentioned 16/4/19 Close Change% Potential Upside
    1 1 XRO [XERO] 11/2/19 $ 46.200 $ 51.320 11.1% Phase 3-4 ; growth & getting in profitability
    2 2 MYE [MASTERMYNE] 11/2/19 $ 0.840 $ 0.860 2.4% Phase 4- growth
    3 3 CLV [CLOVER] 11/2/19 $ 1.525 $ 2.020 32.5% Phase 4- growth
    4 4 SFC [SCHAEFFER] 12/2/19 $ 14.480 $ 13.000 -10.2% Phase 4-growth
    5 5 YOW [YOWIE] [closed] 19/2/19 $ 0.070 $ 0.090 28.6% Phase 3-validated; shareholder conflict
    6 6 CAT [CATAPULT] [closed] 21/2/19 $ 0.640 $ 0.840 31.3% Phase 3-validated; governance issue
    7 7 PME [PROMEDICUS] 21/2/19 $ 14.45 $ 17.55 21.5% Phase 4-growth
    8 8 VHT [VOLPARA] 6/3/19 $ 1.185 $ 1.825 54.0% Phase 2-3 -validating & ramping
    9 9 NST [NORTHERN STAR] 8/3/19 $ 8.87 $ 8.95 0.9% Phase 4- defensive growth
    10 10 ANO [ADVANCED NANOTEK] [re-opened] 8/3/19 $ 3.05 $ 4.44 45.6% Phase 4-growth
    11 11 CYL [CATALYST METALS] 13/3/19 $ 2.30 $ 2.08 -9.6% Phase 1-positive discovery
    12 12 NUH [NUHEARA] [closed] 13/3/19 $ 0.069 $ 0.061 -11.6% Phase 1-2 nearing validation; governance issue
    13 13 MWY [MIDWAY] 14/3/19 $ 3.980 $ 3.580 -10.1% Phase 4- growth
    14 14 D20 [DUXTON WATER] 27/3/19 $ 1.580 $ 1.600 1.3% Phase 4-defensive growth & scalability
    15 15 PNV [POLYNOVO] 1/4/19 $ 0.760 $ 0.930 22.4% Phase 2-3- validated & ramping & getting into profitability
    16 16 DUB [DUBBER] 8/4/19 $ 0.925 $ 0.950 2.7% Phase 2-3- validated & ramping
    17 17 TTT [TITOMIC] 8/4/19 $ 2.300 $ 2.400 4.3% Phase 1-positive discovery
    18 18 EVS [ENVIROSUITE] 10/4/19 $ 0.170 $ 0.165 -2.9% Phase 2-3- validated & ramping
    19 19 AD8 [AUDINATE] 10/4/19 $ 6.290 $ 6.400 1.7% Phase 3- validated, ramping into profitable growth
    20   LOTTERY STOCKS          
    21 20 4DS [4DS] 20/2/19 $ 0.067 $ 0.075 11.9% Phase 1-positive discovery
    22 21 BIT [BIOTRON] 20/2/19 $ 0.090 $ 0.094 4.4% Phase 1-positive discovery
    23 22 ACW [ACTINOGEN] 20/2/19 $ 0.054 $ 0.052 -3.7% Phase 1-positive discovery
    24   COMPOSITE RETURN%       10.4%  
    25   SMALL CAP ORDS RETURN% SINCE 11/2/19       5.5%  
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.